Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

A clinical objective IMRT QA method based on portal dosimetry and electronic portal imager device (EPID) measurement.

Zhang M, Qin S, Chen T, Kim S, Jabbour S, Haffty B, Yue NJ.

Technol Cancer Res Treat. 2013 Apr;12(2):145-50. doi: 10.7785/tcrt.2012.500314. Epub 2012 Dec 26.

PMID:
23289479
2.

Clinical introduction of a linac head-mounted 2D detector array based quality assurance system in head and neck IMRT.

Korevaar EW, Wauben DJ, van der Hulst PC, Langendijk JA, Van't Veld AA.

Radiother Oncol. 2011 Sep;100(3):446-52. doi: 10.1016/j.radonc.2011.09.007. Epub 2011 Sep 29.

PMID:
21963288
3.

A Varian DynaLog file-based procedure for patient dose-volume histogram-based IMRT QA.

Calvo-Ortega JF, Teke T, Moragues S, Pozo M, Casals-Farran J.

J Appl Clin Med Phys. 2014 Mar 6;15(2):4665. doi: 10.1120/jacmp.v15i2.4665.

PMID:
24710455
4.

Patient specific pre-treatment QA verification using an EPID approach.

Vazquez Quino LA, Chen X, Fitzpatrick M, Shi C, Stathakis S, Gutierrez A, Esquivel C, Mavroidis P, Alkhatib H, Papanikolaou N.

Technol Cancer Res Treat. 2014 Feb;13(1):1-10. doi: 10.7785/tcrt.2012.500351. Epub 2013 Jun 24.

PMID:
23819492
5.

3D dose reconstruction for clinical evaluation of IMRT pretreatment verification with an EPID.

van Zijtveld M, Dirkx ML, de Boer HC, Heijmen BJ.

Radiother Oncol. 2007 Feb;82(2):201-7. Epub 2007 Feb 6.

PMID:
17287039
6.

A comparison of the gamma index analysis in various commercial IMRT/VMAT QA systems.

Hussein M, Rowshanfarzad P, Ebert MA, Nisbet A, Clark CH.

Radiother Oncol. 2013 Dec;109(3):370-6. doi: 10.1016/j.radonc.2013.08.048. Epub 2013 Oct 4.

PMID:
24100148
7.

Characterization and clinical evaluation of a novel IMRT quality assurance system.

Sadagopan R, Bencomo JA, Martin RL, Nilsson G, Matzen T, Balter PA.

J Appl Clin Med Phys. 2009 May 7;10(2):2928.

PMID:
19458595
8.

Fast, daily linac verification for segmented IMRT using electronic portal imaging.

Vieira SC, Bolt RA, Dirkx ML, Visser AG, Heijmen BJ.

Radiother Oncol. 2006 Jul;80(1):86-92. Epub 2006 Jul 18.

PMID:
16854483
9.

A quality assurance method that utilizes 3D dosimetry and facilitates clinical interpretation.

Oldham M, Thomas A, O'Daniel J, Juang T, Ibbott G, Adamovics J, Kirkpatrick JP.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):540-6. doi: 10.1016/j.ijrobp.2011.12.015. Epub 2012 Feb 22.

10.

Formulation and initial experience on patient specific quality assurance for clinical implementation of dynamic IMRT.

Krishnamurthy K, Sivakumar SS, Davis CA, Ravichandran R, El Ghamrawy K.

Gulf J Oncolog. 2009 Jan;(5):44-8.

PMID:
20084785
11.

Patient-specific quality assurance for the delivery of (60)Co intensity modulated radiation therapy subject to a 0.35-T lateral magnetic field.

Li HH, Rodriguez VL, Green OL, Hu Y, Kashani R, Wooten HO, Yang D, Mutic S.

Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):65-72. doi: 10.1016/j.ijrobp.2014.09.008. Epub 2014 Oct 25.

12.

Volumetric-modulated arc therapy: effective and efficient end-to-end patient-specific quality assurance.

O'Daniel J, Das S, Wu QJ, Yin FF.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1567-74. doi: 10.1016/j.ijrobp.2011.01.018. Epub 2011 Apr 4.

PMID:
21470797
13.

Toward optimizing patient-specific IMRT QA techniques in the accurate detection of dosimetrically acceptable and unacceptable patient plans.

McKenzie EM, Balter PA, Stingo FC, Jones J, Followill DS, Kry SF.

Med Phys. 2014 Dec;41(12):121702. doi: 10.1118/1.4899177.

14.

The evolution of quality assurance for intensity- modulated radiation therapy (IMRT): sequential tomotherapy.

Woo SY, Grant W 3rd, McGary JE, Teh BS, Butler EB.

Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):274-86.

PMID:
12694849
15.

Optimization and quality assurance of an image-guided radiation therapy system for intensity-modulated radiation therapy radiotherapy.

Tsai JS, Micaily B, Miyamoto C.

Med Dosim. 2012 Autumn;37(3):321-33. doi: 10.1016/j.meddos.2011.11.006. Epub 2012 Mar 13.

PMID:
22417899
16.

Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA.

Zhen H, Nelms BE, Tome WA.

Med Phys. 2011 Oct;38(10):5477-89. doi: 10.1118/1.3633904.

PMID:
21992366
17.

Monte Carlo simulations to replace film dosimetry in IMRT verification.

Goetzfried T, Rickhey M, Treutwein M, Koelbl O, Bogner L.

Z Med Phys. 2011;21(1):19-25. doi: 10.1016/j.zemedi.2010.05.002.

PMID:
20888202
18.

Institutional patient-specific IMRT QA does not predict unacceptable plan delivery.

Kry SF, Molineu A, Kerns JR, Faught AM, Huang JY, Pulliam KB, Tonigan J, Alvarez P, Stingo F, Followill DS.

Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1195-201. doi: 10.1016/j.ijrobp.2014.08.334. Epub 2014 Oct 21.

19.

Independent verification of gantry angle for pre-treatment VMAT QA using EPID.

Adamson J, Wu Q.

Phys Med Biol. 2012 Oct 21;57(20):6587-600. doi: 10.1088/0031-9155/57/20/6587. Epub 2012 Sep 25.

PMID:
23010739
20.

Pre-segmented 2-Step IMRT with subsequent direct machine parameter optimisation - a planning study.

Bratengeier K, Meyer J, Flentje M.

Radiat Oncol. 2008 Nov 6;3:38. doi: 10.1186/1748-717X-3-38.

Supplemental Content

Support Center